Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/2143
Title: Endometriosis: alternative methods of medical treatment.
Authors: Muñoz-Hernando, Leticia
Muñoz-Gonzalez, Jose L
Marqueta-Marques, Laura
Alvarez-Conejo, Carmen
Tejerizo-García, Álvaro
Lopez-Gonzalez, Gregorio
Villegas-Muñoz, Emilia
Martin-Jimenez, Angel
Jiménez-López, Jesús S
metadata.dc.contributor.authoraffiliation: [Muñoz-Hernando,L; Muñoz-Gonzalez,JL; Marqueta-Marques,L; Alvarez-Conejo,C; Tejerizo-García,A; Lopez-Gonzalez,G; Jiménez-López,JS] Endometriosis Unit, Service of Obstetrics and Gynecology, Hospital Universitario 12 de Octubre, Madrid, Spain. [Villegas-Muñoz,E] Endometriosis Unit, Service of Obstetrics and Gynecology, Hospital Carlos Haya, Malaga, Spain. [Martin-Jimenez,A] Endometriosis Unit, Service of Obstetrics and Gynecology, Hospital Son Llatzer, Palma de Mallorca, Spain.
Keywords: Pharmacological treatment options;Aromatase inhibitors;GnRH antagonists;Selective progesterone receptor modulators;Anti-TNF-α;Endometrial tissue;Antiangiogenic factors;Hormonal treatments;Inductores de la angiogénesis;Inhibidores de la aromatasa;Endometriosis;Estrógenos;Femenino;Hormona liberadora de gonadotropinas;Dolor;Resultado del tratamiento
metadata.dc.subject.mesh: Medical Subject Headings::Diseases::Female Urogenital Diseases and Pregnancy Complications::Female Urogenital Diseases::Genital Diseases, Female::Endometriosis
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Aromatase Inhibitors
Medical Subject Headings::Diseases::Female Urogenital Diseases and Pregnancy Complications::Female Urogenital Diseases::Genital Diseases, Female::Endometriosis
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Estrogens
Medical Subject Headings::Check Tags::Female
Medical Subject Headings::Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Hypothalamic Hormones::Pituitary Hormone-Releasing Hormones::Gonadotropin-Releasing Hormone
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Pain
Medical Subject Headings::Chemicals and Drugs::Pharmaceutical Preparations
Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Transcription Factors::Receptors, Cytoplasmic and Nuclear::Receptors, Steroid::Receptors, Progesterone
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome
Issue Date: 11-Jun-2015
Publisher: Dove Medical Press
Citation: Muñoz-Hernando L, Muñoz-Gonzalez JL, Marqueta-Marques L, Alvarez-Conejo C, Tejerizo-García Á, Lopez-Gonzalez G, et al. Endometriosis: alternative methods of medical treatment. Int J Womens Health. 2015; 7:595-603
Abstract: Endometriosis is an inflammatory estrogen-dependent disease defined by the presence of endometrial glands and stroma at extrauterine sites. The main purpose of endometriosis management is alleviating pain associated to the disease. This can be achieved surgically or medically, although in most women a combination of both treatments is required. Long-term medical treatment is usually needed in most women. Unfortunately, in most cases, pain symptoms recur between 6 months and 12 months once treatment is stopped. The authors conducted a literature search for English original articles, related to new medical treatments of endometriosis in humans, including articles published in PubMed, Medline, and the Cochrane Library. Keywords included "endometriosis" matched with "medical treatment", "new treatment", "GnRH antagonists", "Aromatase inhibitors", "selective progesterone receptor modulators", "anti-TNF α", and "anti-angiogenic factors". Hormonal treatments currently available are effective in the relief of pain associated to endometriosis. Among new hormonal drugs, association to aromatase inhibitors could be effective in the treatment of women who do not respond to conventional therapies. GnRH antagonists are expected to be as effective as GnRH agonists, but with easier administration (oral). There is a need to find effective treatments that do not block the ovarian function. For this purpose, antiangiogenic factors could be important components of endometriosis therapy in the future. Upcoming researches and controlled clinical trials should focus on these drugs.
Description: Journal Article;
URI: http://hdl.handle.net/10668/2143
metadata.dc.relation.publisherversion: https://www.dovepress.com/endometriosis-alternative-methods-of-medical-treatment-peer-reviewed-article-IJWH#
metadata.dc.identifier.doi: 10.2147/IJWH.S78829
ISSN: 1179-1411 (Online)
Appears in Collections:01- Artículos - Hospital Regional de Málaga

Files in This Item:
File Description SizeFormat 
MunozHernandoL_EndometriosisAlternative.pdfArtículo publicado232,69 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons